Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 3471-3480 of 10980

Edit search filters
  1. Pazopanib Hydrochloride in Treating Patients with Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

    Jacksonville, FL, Rochester, MN

  2. Long-Term Safety of PF-00547659 in Ulcerative Colitis

    Scottsdale/Phoenix, AZ

  3. The Penumbra Liberty Trial: Safety and Effectiveness in the Treatment of Wide-Neck Intracranial Aneurysms

    Jacksonville, FL

  4. A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

    Rochester, MN

  5. Study of LY2784544 Testing Alternative Dosing in Participants with Myeloproliferative Neoplasms

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  6. DN24-02 as Adjuvant Therapy in Subjects with High Risk HER2+ Urothelial Carcinoma

  7. Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study

    Rochester, MN

  8. Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion

    Rochester, MN

  9. Single-Ascending Dose Study of JK07 in Subjects With HFpEF

    Rochester, MN

  10. Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss (DEKS)

    Rochester, MN

.

Mayo Clinic Footer